Nicolas Hantzsch

Three biggest learnings from a fundraising journey. Shared by Rainer Märkle, General Partner at HV Capital at EUVC 1/ Have a time box with a deadline attached. Have a defined horizon & create a clear plan. Have some urgency to get things done at some point. Execute very transparently and reliably. 2/ Stick to your narrative. But don't do it blindly. Tweak it when necessary. Adapt it. Don't let yourself be surprised by major changes. Keep focusing on delivering according to your strategy & plan. 3/ Fundraising is a marathon with many sprints. There are moments when you'll ask yourself - Why do I do this? Is it gonna work out? But don't get too negative during the down phases. Adapting and pivoting is part of our job. As it is for the founder of a company. How about you? What fundraising lessons have you learned? Join the conversation. 🔽 #venturecapital #angelinvesting #startupfunding #europe

5

1 Kommentar

Attention of partners, managers, investment directors and private investors investing in Healthtech. Usually they ask you for money and participation in demo day. From me personally and the 4PM Ventures team for you another offer: 1. Please read our post below and express your opinion - do you agree with these theses or not. 2. Ask clarifying questions if they appear. 3. Add to friends if we do not know each other yet. 4. Send our offer to take part in the laboratory to your portfolio companies - the start of the program - a new format for supporting startups, supported by EIT Health, on June 12th. 5. Request an invitation to open a laboratory and a foresight about the future of healthcare, which will take place within the laboratory. More information about the laboratory on the 4PM Ventures page, link to registration in the first comment Dear colleagues, please note this offer: Nathan Kharchenko, Valentin Doronichev; Anna Gishko; Allan Gobbs; Yuri Mashintsev; Jacopo Mele; Marija Varadinova; Yury Kukushkin; Khaled Arwani; Kirill Vesselov; Nikolai Denisov Commercialization Reactor; Zaz Ventures Change Ventures LongeVC; Coöperatie VGZ #4pm; #vc; #health; #healthtech; #medicine

11

2 Kommentare

Lifescience investors, this is for you! Invest in the best hand-picked and validated by industry leaders startups! 💰 This year Caelestinus accelerator was highly effective. I want to highlight the best achievements we've done together with startups within the InterSystems innovations ecosystem during the 4-month program. Let's start with ROOK - one of the top-performing businesses! ✅ Revenue approaching $1M in ARR ✅ 100k active users ✅ 30 clients ✅ 3 pilots as of today, all with the integration of InterSystems' IRIS ✅ Received a grant, and participated in the InterSystems Global Summit (Miami, USA) Also, I have no idea, how Marco Benitez and Jonas Dücker found the time to support other participants and be so dedicated to community goals. But they did! These guys are worth building business with and investing in. My personal recommendation! Don't hesitate to reach them out! #healthtech #venturecapital #growth #medtech #mentorship #GTM

13

6 Kommentare

Private capital has huge potential to help develop a local ecosystem. It is the fuel for the local engine (startups and founders) to work. However, in biotech, local ecosystem dont thrive isolated but connected to the larger ones. Florian Schuster and Christopher Trummer seems to be doing this at Venga Ventures. From the little I have seen here, the idea is to connect Austria to the larger biotech league. If successful, the value created by these companies is spreaded between all engaged countries. If I understood this correctly, I share the excitement of this strategy and believe there is great technology to be developed outside of the larger biotech places of the world (think Boston, San Francisco, New York, San Diego and London), but that do not have a fighting chance if not connected to them somehow. Some local VCs in Brazil and Latan are doing this too like Vesper Biotechnologies and Zentynel Frontier Investments but there is room for more. Looking forward to hear from Venga Ventures and its companies in the future. Congrats and good luck!

13

Stay tuned for our upcoming panel at the Health.Tech Conference in Munich 4:35pm tomorrow! We'll dive deep into the world of venture debt with a team of seasoned experts with the lenses of entrepreneurs, investors and venture debt lenders. Join us as we unravel the complexities of this financing tool and explore how it could be the key to unlocking your next growth strategy. Our panelists include: Christian Köhler, Chris Church, Daniel Mallon, George van Dorp, Humphrey Nokes See you tomorrow! #HealthTech #VentureDebt #GrowthStrategy #FinancePanel #healthtech

55

5 Kommentare

Today I visited the GREENTECH FESTIVAL in Berlin with my dear friend Andreas. 💚 To make it short: Good vibes, busy floors and a big startup space. But tbh I wondered if it's really worth it for startups. I remember from my active time as an exhibitor that we weren't honest about the hard costs per lead. We argued a lot: being there is everything, you have to be seen, brand building is important, it's where the industry meets, serendipity happens, if we just get one big order it will pay off... not to forget the parties! That's all true, but the opportunity cost of attending a trade show is very high, especially for startups. And while this isn't meant to be a trade show bashing at all, here are a few suggestions from my experience, on how to make the most of it... - Train your team to proactively approach people. - Initiate a challenge to see who can get the most leads. - Prepare in advance and market your attendance by actively inviting customers. - Consider a small side event, such as a VIP dinner. - Try to book a package with a speaking engagement at the conference, that has always paid off for us. - Use the exhibitor directory for your own prospecting. - Calculate cost vs. lead conversion after the show with real data and decide whether to repeat. - Push your presence on social in real time. Good luck to all exhibitors and happy selling 🚀 ____________________________ Sharing my experience as an entrepreneur and angel investor. Investing in early stage B2B SaaS startups. Happy to connect 👋

62

9 Kommentare

I’m thrilled to announce my upcoming speaking engagement at the Health Tech Conference by Bits & Pretzels in Munich. Join me for a session titled “Ready, Set, Raise: Insights for Fundraising Success.” This isn’t your run-of-the-mill fundraising workshop. We’re diving deep into strategic, high-level fundraising tailored for companies gearing up to Series B. 🔍 Let’s explore advanced strategies together, aligning business goals with market dynamics, innovating capital structuring, and optimizing investor relations. These insights aren’t just theories; they’re actionable, proven methods to guide mature companies through complex fundraising landscapes. Don’t miss out on this transformative experience designed to elevate your fundraising game. Let’s unlock new opportunities together and propel your business to new heights. Whether you’re refining your strategy or seeking fresh perspectives on engaging modern investors, this session is tailored for you. 🗓 Save the date: June 6, 2024. 11:30 AM - 12:10 PM 📍 Munich, Germany - International Congress Center Messe (ICM) Looking forward to connecting with fellow entrepreneurs and innovators at the health.tech conference! See you there! ➡️ Use Discount Code: KARIC_20 ➡️ Link to tickets: https://bit.ly/Kari-C Secure your ticket now and enjoy a 20% discount! #HT24 #healthtech #innovation #networking #growth

62

5 Kommentare

I'm speaking at SuperVenture 2024 on the 5th of June in Berlin. The topic of the panel is emerging VC managers: time to shine or out of their depth? Are LPs fleeing to established names and those that cut their teeth during previous cycles? Or is now the time for emerging managers to bring something different to the table? Is volatility leading to true innovation and disruption? We’re on track to see approximately 44% of the total LP capital committed to US VC funds since the start of the year go to just two large established VC platforms, according to PitchBook data. While many established VCs maintain their allure, there is a subset of LPs who are making a deliberate choice to increase their allocations to specialist emerging VC managers - managers who have spun out from established funds and have an attributable track record, founders with deep operational experience turned funders or academics with deep domain expertise. There is non-trivial added complexity when it comes to emerging VC selection – given the large number of funds needed to be screened and the more complicated referencing and DD process. Data highlights how important it is for GPs to identify & back ‘big winners’ early on to drive fund returns. Typically, ~5% of invested capital in a few winners drives most of the return (>50%). The VC model is built around investing in early-stage companies each with the potential to more than return the whole fund. Who has the right to win? Who will the best founders (and LPs) decide to partner with? #SuperVenture #VC SuperReturn

77

7 Kommentare

Welcome ecoLocked to the Climentum Capital portfolio! We are proud to have led the €4M funding round together with Matterwave Ventures, and delighted to have existing investors Counteract, Startup Family Office, Sabancı Building Solutions, and VOYAGERS.io joining the round. The investment will support ecoLocked’s mission to revolutionize the construction industry with carbon-negative building materials. Concrete production accounts for 8% of global CO2 emissions, making innovations in this field crucial for achieving net-zero goals. ecoLocked is leading the change by converting carbon captured from biomass into functional, carbon-negative building materials. This funding will accelerate ecolocked's efforts to turn buildings into carbon sinks, scaling their innovative biochar-based solutions and enabling 1Gt carbon removal by 2040. Doerte Hirschberg Morten Halborg Stefan Maard

68

6 Kommentare

🧚‍♀️ Luck is a skillset! What do you say? 🦄 Sometimes all it takes is to be in the right place at the right time… Join the likes of Elvie, ŌURA, Flo Health Inc., and many other #FemTech companies to showcase your product while meeting key stakeholders: NHS, VCs, angels, big Pharma, big Tech, and hundreds of potential partners. 😇 There are a couple of exhibitor spots left for this year’s Decoding the Future of Women conference. Should one be reserved for you? Cheeky I know, but it IS officially the most awaited event of the year for the FemTech community so I thought I'd ask! 💥 Showcase your product and brand to corporates, NHS, pharma, and decision-makers in Women’s Health 💥 Use the event app to schedule meetings with high-potential event attendees 💥 Get your branding/ logos on all event signage and digital event promotions Who can exhibit? ✅ Products and solutions within the FemTech space ✅ Startups and scale-ups who have a product to demo or showcase ✅ Supporters and service providers Email me to find out more about exhibitor fees and how to get started. If you're still unsure, quickly go get your ticket before the price goes up on May 7th! 🦹‍♀️ ❤️ Let's change the World for Women together!

82

1 Kommentar

Awesome report from Rock Health (in the comments) about H124 digital health funding. 📈 Despite broader economic challenges, the digital health sector, including mental health, has shown resilience, raising $5.7B across 266 deals. There is a strong Series A pipeline, tapering off of unlabeled funding rounds and 3 public exits in Q2 2024 indicating a revival in the exit market and a return to more sustainable funding patterns​. Key insights about the mental health market: 🧠 Mental health continues to be the leading clinical indication in digital health funding, securing $682 million in H1 2024. This consistent top ranking highlights the ongoing investor interest and the market's recognition of the critical need for mental health solutions. 🤖 The focus on mental health is driven by a combination of increased awareness, the rising demand for accessible mental health services, and the integration of tech solutions...🙄 In fact, AI has become a significant factor in digital health investments, with 34% of the total sector funding going to AI-startups. This trend is also reflected in mental health, where AI is being utilised to enhance diagnosis, personalise treatment plans, and provide scalable, efficient care solutions. Let's go!

22

1 Kommentar

Start-ups in digital health face a strange paradox. Let me explain why! Your users want to know that you care and will be with them during good times and bad. Therefore “establishing trust is job one” for every health company as popularly stated by Karen DeSalvo, Chief Health Officer, Google Health! Quite paradoxically the nature of startups is fleeting. Throughout your journey you are answering “existential questions”! Even if you have the capital, it is probably not patient enough to help you “build a brand” that users trust. Well then how else can you communicate to your users and patients that you are in it for the long run? That you are going to survive irrespective of funding winters? That’s where long-term thinking becomes extremely important for founders. Believing in your mission and conditioning your “cockroach mentality” are just a few ways! In fact, every extra year that you survive as a healthtech startup truly compounds the “trust” that you build with your patients. Well how do you measure this trust? There are many ways you can do it! At Evolve, we recently hit an important landmark of 1 million users while maintaining a rating of more than 4.5 stars across both Play Store and App Store! Is that enough? Maybe not. But we still have another 10years to go 🚀

229

32 Kommentare

At our VC firm, we don't just fund companies, we fund your existential crises. Every investment comes with a complimentary philosophy book. #vc #startups #investment

8

According to the latest report from Rock Health, digital health funding in Q1 2024 totaled $2.7B across 133 deals, with an average deal size of $20.6M. It doesn’t break out device-related investments, but most medtech founders I meet these days are being forced to chase tiny rounds made up of endless little checks, consuming valuable energy and slowing their progress. The benign neglect of this next generation of diagnostic and therapeutic devices is counterproductive and surprising. Given the crowded virtual care market, for example, I’d expect more such companies would be exploring medtech partnerships, investments or acquisitions that'd enable them to back integrate into delivering sharper, and more differentiated, care and treatment. This is exactly what Maverix Medical is doing from the other direction: Reshaping the entire spectrum of lung cancer care by integrating more advanced + effective approaches to screening and diagnosis, treatment and therapeutics, and even palliative care…And putting it all to work through an innovative provider network. One notable investor exception is Y Combinator partner Surbhi Sarna who’s been backing great teams like Selera Medical (YC W24) doing foundational work on ambitious medical devices. Without more support from investors like her, we’re going to increasingly find ourselves stuck with the incremental portfolio improvements from the incumbents, and that’s just not nearly enough.

58

5 Kommentare

🔬 Health Innovation Thrives in Amsterdam! Last week, I attended HLTH Europe in Amsterdam, one of Europe’s premier health tech events. Here are my key takeaways after 3 days of conferences and insightful discussions: 💜 Empowering Women's Health Beyond Pregnancy Lesley Regan's interventions were truly enlightening. Women's health should encompass more than just pregnancy. We must ensure better care access and greater inclusion in clinical trials for a more equitable healthcare system. 🏨 AI: Revolutionizing Hospital Efficiency AI emerged as a pivotal solution to address hospital inefficiencies, from streamlining operational tasks to enhancing predictive medicine. The potential for AI in healthcare is immense, and it’s clear that we can significantly improve patient outcomes and operational efficiency with the right data strategies. 💊 From Curative to Predictive Care: A New Frontier The journey from curative to predictive care has just begun, sparking important discussions about the roles of insurance providers, digital therapeutics (DTx), and government. At IRIS, with Anais Monlong, Julien-David Nitlech, Thorben Rothe Jan-Soeren Zinke and François Kergaravat strongly believe that tech must be part of the future of healthcare 💪

49

4 Kommentare

Thanks Rachel Braun Scherl for shedding light on this ! One of key markers investors look for in early stage companies is the evidence of deep understanding of your customer and your domain. Women building in femtech not only understand the problems personally but have tremendous conviction to solve them. We at She Raises Capital are proud to be working with so many female founders building in femtech . Pipeline issue is a myth! Looking to to back trailblazing women with high growth femtech businesses? Simply reach out. Shalini Sardana (She/Her) , Diane Bailey, Alice Zheng , Springboard Enterprises, Janna Meyrowitz Turner , Azin Radsan van Alebeek , Sophia Yen, MD, MPH , The Female Quotient #femtech #fundinggap #investmentreadiness #dealflow #customer #emotionalhook #convictions #purpose #founderjourney #earlystageinvesting #femtechinvestor

16

1 Kommentar

https://lnkd.in/epFgH79T You’ve probably read tons of articles about the different rounds of VC funding and all the associated terms, but how often do you come across something that really breaks down the numbers? Ever wondered how to keep track of your startup’s equity as you grow? Dive into our hands-on guide to cap tables, where I break down everything from your first seed round to that exciting exit moment.  By walking you through various scenarios and terms with comprehensive examples and visual aids, I offer a solid foundation for managing equity financing in startups. While real-world cap tables can be intricate, this primer ensures fair ownership and proceeds distribution, helping you maintain investor confidence and support your startup’s long-term growth.Let’s get your cap table game on point!